Biomerica (NASDAQ: BMRA) director lifts stake to 73,542 shares
Rhea-AI Filing Summary
BIOMERICA INC (BMRA) director and Executive Vice Chairman Allen Barbieri reported a purchase of 20,000 shares of common stock on August 26, 2026. The shares were acquired at $1.60 per share in a private placement by Biomerica under a Securities Purchase Agreement dated August 20, 2026. Following this transaction, Barbieri directly holds 73,542 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 20,000 shares
Net Buy
1 txn
Insider
BARBIERI ALLEN
Role
Executive Vice Chairman
Bought
20,000 shs ($32K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common stock F1 | 20,000 | $1.60 | $32K |
Holdings After Transaction:
Common stock — 73,542 shares (Direct)
Footnotes (1)
- F1. On August 26, 2026, the reporting person acquired 20,000 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers.
Key Figures
Shares purchased: 20,000 shares of common stock
Purchase price per share: $1.60 per share
Shares owned after transaction: 73,542 shares
+1 more
4 metrics
Shares purchased
20,000 shares of common stock
Purchased on August 26, 2026 in a private placement
Purchase price per share
$1.60 per share
Price paid for BMRA common stock in the private placement
Shares owned after transaction
73,542 shares
Direct BMRA common stock holdings of Allen Barbieri after the purchase
Transaction date
August 26, 2026
Date of the reported BMRA common stock purchase
Key Terms
private placement, Securities Purchase Agreement, institutional investors, Board of Directors
4 terms
private placement financial
"acquired 20,000 shares ... in private placement by the Issuer"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Securities Purchase Agreement financial
"pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
institutional investors financial
"by and among certain institutional and individual investors identified"
Institutional investors are large organizations, like pension funds, insurance companies, and mutual funds, that invest huge amounts of money on behalf of many people. Their decisions can influence the economy because they buy and sell big chunks of stocks, bonds, or other assets. They matter because their actions can affect market prices and trends.
Board of Directors financial
"which included among others ... certain members of the Company's Board of Directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
What insider transaction did BMRA report for Allen Barbieri?
Allen Barbieri reported purchasing 20,000 BMRA common shares on August 26, 2026, at $1.60 per share in a private placement conducted by Biomerica. After this transaction, he directly holds 73,542 shares of the company’s common stock.
Was the BMRA insider trade by Allen Barbieri a buy or a sell?
The reported BMRA insider trade by Allen Barbieri was a buy. He purchased 20,000 common shares at $1.60 per share in a private placement on August 26, 2026, increasing his direct holdings to 73,542 shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
